ULBI (Ultralife) Cyclically Adjusted Revenue per Share: $9.08 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ULBI Ultralife Corp ULBI
72 GF Score
Price $7.48
GF Value $8.85
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Ultralife Cyclically Adjusted Revenue per Share?

Ultralife ULBI +0.94% 72 Cyclically Adjusted Revenue per Share is $9.08 as of Jun. 2026. GuruFocus rates ULBI with a GF Score™ of 72/100 and a GF Value™ of $8.85 (Modestly Undervalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Ultralife's adjusted revenue per share for the three months ended in Jun. 2026 was $2.868. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $9.08 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Ultralife's average Cyclically Adjusted Revenue Growth Rate was 8.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.80% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was -0.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Ultralife was 19.70% per year. The lowest was -8.40% per year. And the median was 7.30% per year.

As of today (2026-08-16), Ultralife's current stock price is $7.48. Ultralife's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was $9.08. Ultralife's Cyclically Adjusted PS Ratio of today is 0.82.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ultralife was 1.71. The lowest was 0.47. And the median was 0.98.


Ultralife  (NAS:ULBI) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Ultralife's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=7.48/9.08
=0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ultralife was 1.71. The lowest was 0.47. And the median was 0.98.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Ultralife Cyclically Adjusted Revenue per Share Related Terms


Ultralife Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Ultralife's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ultralife Cyclically Adjusted Revenue per Share Chart

Ultralife Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.12 6.59 7.20 7.88 8.61

Ultralife Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.35 8.50 8.61 8.88 9.08

ULBI vs NMAD, TGEN, APWC: Cyclically Adjusted Revenue per Share Comparison

For the Electrical Equipment & Parts subindustry, Ultralife's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ultralife Cyclically Adjusted PS Ratio vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Ultralife's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ultralife's Cyclically Adjusted PS Ratio falls into.


ULBI
72GF Score
Ultralife Corp ULBI
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ultralife Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ultralife's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2.868/333.9520*333.9520
=2.868

Current CPI (Jun. 2026) = 333.9520.

Ultralife Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 1.283 241.428 1.775
201612 1.415 241.432 1.957
201703 1.407 243.801 1.927
201706 1.258 244.955 1.715
201709 1.318 246.819 1.783
201712 1.409 246.524 1.909
201803 1.424 249.554 1.906
201806 1.384 251.989 1.834
201809 1.230 252.439 1.627
201812 1.294 251.233 1.720
201903 1.164 254.202 1.529
201906 1.815 256.143 2.366
201909 1.701 256.759 2.212
201912 1.903 256.974 2.473
202003 1.605 258.115 2.077
202006 1.770 257.797 2.293
202009 1.514 260.280 1.943
202012 1.803 260.474 2.312
202103 1.608 264.877 2.027
202106 1.646 271.696 2.023
202109 1.355 274.310 1.650
202112 1.477 278.802 1.769
202203 1.886 287.504 2.191
202206 1.989 296.311 2.242
202209 2.060 296.808 2.318
202212 2.238 296.797 2.518
202303 1.978 301.836 2.188
202306 2.644 305.109 2.894
202309 2.422 307.789 2.628
202312 2.719 306.746 2.960
202403 2.538 312.332 2.714
202406 2.555 314.175 2.716
202409 2.115 315.301 2.240
202412 2.604 315.605 2.755
202503 3.042 319.799 3.177
202506 2.916 322.561 3.019
202509 2.605 324.800 2.678
202512 2.911 324.054 3.000
202603 2.848 330.213 2.880
202606 2.868 333.952 2.868

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $9.08 mean?
Ultralife (ULBI) has a Cyclically Adjusted Revenue per Share of $9.08 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ultralife and its competitors.
Is Ultralife's Cyclically Adjusted Revenue per Share too high?
Ultralife's current Cyclically Adjusted Revenue per Share is $9.08. Overall, Ultralife has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ultralife's Cyclically Adjusted Revenue per Share compare to NMAD and TGEN?
Ultralife's Cyclically Adjusted Revenue per Share of $9.08 can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for an Industrial Products company?
A good Cyclically Adjusted Revenue per Share depends on the Industrial Products industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ultralife and its competitors. Ultralife's current Cyclically Adjusted Revenue per Share is $9.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ultralife stock overvalued right now?
Based on GuruFocus' analysis, Ultralife (ULBI) is currently considered Modestly Undervalued. The stock's GF Value™ is $8.85, compared to a current price of $7.48 — trading 15.5% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $9.08. Ultralife's overall GF Score™ is 72/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Ultralife (ULBI), the current Cyclically Adjusted Revenue per Share is $9.08 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ultralife (ULBI) Overvalued in 2026?

Based on GuruFocus' analysis, Ultralife stock appears to be undervalued. The current stock price of $7.48 is trading 15.5% below its estimated GF Value™ of $8.85. GuruFocus considers Ultralife to be Modestly Undervalued.

Key valuation signals for ULBI:

  • Cyclically Adjusted Revenue per Share: $9.08
  • GF Value™: $8.85 vs. price of $7.48 (15.5% below fair value)
  • GF Score™: 72/100 with 8 warning signs

No single metric tells the full story. See the ULBI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ultralife Business Description

Other Exchanges ULB:Germany
Address 2000 Technology Parkway, Newark, NY, USA, 14513
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company also designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.
72GF Score

Get the complete analysis for ULBI

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.48
Price
$8.85
GF Value